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Objective: Intraoperative cerebral microemboli are associated with the development
of postoperative stroke and neurocognitive decline in patients undergoing coronary
artery bypass grafting. Although cardiopulmonary bypass is responsible for the
generation of a significant number of such emboli, the elimination of cardiopulmo-
nary bypass alone has not been conclusively shown to improve neurocognitive
outcome. The current study was performed to determine the effects of combined
off-pump coronary artery bypass grafting and sutureless proximal aortic anasto-
motic techniques on the generation of intraoperative cerebral microemboli com-
pared with standard coronary artery bypass grafting techniques of cardiopulmonary
bypass and hand-sewn proximal anastomoses.
Methods: Fifty-three patients underwent off-pump coronary artery bypass grafting
by using the sutureless Symmetry aortic connector device (St Jude Medical, St Paul,
Minn) for all proximal anastomoses. Eighteen of these patients received intraoper-
ative transcranial Doppler ultrasonography to determine right- and left-sided cere-
bral microembolic counts. These results were compared with those obtained from a
similar group of 17 patients undergoing standard coronary artery bypass grafting, in
whom cardiopulmonary bypass and hand-sewn proximal anastomoses were used.
Results: Our use of the proximal anastomotic device in patients undergoing coro-
nary artery bypass grafting was safe, with no aortic complications, postoperative
strokes, or in-hospital deaths. Microembolic counts to both the right and left cerebral
circulation were significantly reduced in the patients undergoing off-pump coronary
artery bypass grafting (right  21.9  20.7 emboli, left  24.9  19.2 emboli)
compared with those in patients undergoing standard coronary artery bypass graft-
ing (right  181.6  85.3, left  189.9  60.401, P  .0001).
Conclusions: Our use of a sutureless proximal anastomotic device during off-pump
coronary artery bypass grafting is safe and significantly decreases cerebral micro-
embolism when compared with standard coronary artery bypass grafting with
cardiopulmonary bypass and hand-sewn anastomoses. Long-term follow-up is
needed to determine the effects of this technical strategy on neurocognitive out-
come.
From the Departments of Surgerya and An-
esthesiology,b Duke University Medical
Center, Durham, NC.
Supported in part by a grant from St Jude
Medical, Inc, St Paul, Minn.
Received for publication April 29, 2002;
revisions requested June 14, 2002; revi-
sions received Dec 4, 2002; accepted for
publication Jan 14, 2003.
Address for reprints: Kevin P. Landolfo,
MD, Duke University Medical Center, Box
3675, Durham, NC 27710 (E-mail:
Lando001@mc.duke.edu).
J Thorac Cardiovasc Surg 2003;126:1561-7
Copyright © 2003 by The American Asso-
ciation for Thoracic Surgery
0022-5223/2003 $30.00  0
doi:10.1016/S0022-5223(03)01039-0
Scarborough et al Evolving Technology
The Journal of Thoracic and Cardiovascular Surgery ● Volume 126, Number 5 1561
ET
Neurologic dysfunction is a major contrib-utor to postoperative morbidity and mor-tality after coronary artery bypass graft-ing (CABG). The incidence of focalneurologic impairment after this proce-dure has ranged from 1% to 5% in the
literature. In addition to clinical stroke, the potential for
milder neurocognitive dysfunction after cardiac surgery is
being increasingly recognized. An inverse temporal rela-
tionship between the time of the operation and the manifes-
tations of neuropsychologic decline has been suspected on
the basis of initial outcome studies, with the highest inci-
dence of this complication occurring at discharge (50%-
85%).1,2 However, a recent article has shown the incidence
of neurocognitive deterioration after coronary surgery to be
as high as 42% five years after the procedure, indicating that
this type of dysfunction might persist or even progress long
after the immediate postoperative period.3 Concerted efforts
to reduce the incidence of this complication are important
because even mild impairment in neuropsychologic func-
tioning can have significant effects on the quality of life of
the patient.4
The association between cardiopulmonary bypass (CPB)
support during coronary artery surgery and the development
of postoperative neurologic dysfunction is well estab-
lished.5-7 A correlation between the number of emboli dur-
ing CPB and the incidence of postoperative neurocognitive
deterioration has also been demonstrated.8 Transcranial
Doppler ultrasound (TCDU) studies demonstrate significant
embolic load during several intraoperative events. Ascend-
ing aortic cannulation and crossclamping, with subsequent
release of atheromatous debris, are thought to be major
sources of these emboli.9-14 Previous reports have also
demonstrated that the return of shed blood returned directly
to the patient through cardiotomy suction might produce
microembolization. Such blood return through cardiotomy
suction has been purported to cause an increase in small
capillary arterial dilatations, which represent acellular lipoid
deposits in the afferent microvasculature of the brain and
are suspected of causing central nervous system injury after
CPB.15,16 Off-pump CABG (OPCAB) holds promise as a
potential method by which the frequency of intraoperative
cerebral microembolization, and therefore postoperative
neurologic dysfunction, can be reduced. Preliminary inves-
tigations show that off-pump coronary bypass procedures
are associated with significantly fewer cerebral embolic
events than when performed with extracorporeal circula-
tion.17-19 However, the risk of cerebral embolus generation
and thus postoperative neurologic dysfunction is not elim-
inated simply by removing extracorporeal support from
coronary artery bypass procedures. Because atheromatous
emboli have been shown to result from ascending aortic
crossclamping during proximal aorta–vein graft anastomo-
ses, compromise of the cerebral microcirculation remains a
possibility, even during off-pump coronary surgery.20 This
might explain why investigators have not been able to show
uniform improvement in neurocognitive outcome in patients
undergoing off-pump procedures.21-23
The optimal strategy for avoiding intraoperative cerebral
embolic events and, subsequently, postoperative neurologic
dysfunction should therefore include both the elimination of
CPB and the minimization of intraoperative ascending aor-
tic manipulation. We performed the present study to assess
the effects of such a combined strategy on the frequency of
intracerebral microembolic events during CABG. To do
this, we compared the number of such embolic events
during coronary bypass procedures by using either off-
pump surgery in combination with a sutureless proximal
anastomotic device or standard CABG with CPB and tra-
ditional hand-sewn anastomoses with aortic crossclamping.
We hypothesized that, when compared with standard
CABG, a procedure that minimizes aortic manipulation by
eliminating both CPB and aortic crossclamping, the off-
pump would result in fewer intraoperative cerebral micro-
embolic events.
Materials and Methods
Patient Enrollment
After receiving institutional review board approval for the follow-
ing study protocol, 53 patients underwent OPCAB procedures with
the Symmetry proximal aortic anastomotic device (St Jude Med-
ical, St Paul, Minn) during the period between June 2001 and
December 2001. Of these patients, 21 provided written preopera-
tive consent for intraoperative TCDU monitoring (OPCAB group).
A separate group of 26 patients undergoing standard CABG with
CPB and freehand proximal anastomoses during the same time
period also consented to intraoperative TCDU (S-CABG group).
All coronary bypass procedures were performed by the same
surgeon (K.P.L.). The exclusion criteria for enrollment into the
study included patients undergoing multiple arterial grafting and
patients with venous conduits that measured less than 4.0 mm in
outer diameter.
Transcranial Doppler Technique
In 21 patients in the OPCAB group and 26 patients in the S-CABG
group, intraoperative emboli detection was performed by using
two 2-MHz pulse-wave Doppler probes fixed on a special headset
and connected to a DWL Multiflow transcranial Doppler (TCD)
machine (DWL GmbH, Sipplingen, Germany). The parameters
used for the Multiflow TCD were software version 8.27I, scale
between100 and100 cm/s, sample volume of 10 mm, 64-point
fast Fourier transform (FFT), FFT length of 2.2 ms, FFT overlap
of at least 50%, and high-pass filter set at 100 Hz. The separation
between the 2 sample volumes was 5 mm (dual-gate TCD), and the
pulse repetition frequency was set at 6000 Hz. TCD was performed
from the time of skin incision until wound closure. Intraopera-
tively, adjustments were made to obtain the strongest signal pos-
sible. These signals were then recorded continuously on a hard
drive for offline analysis. Postoperatively, the data for each patient
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were analyzed by a member of our team (F.D.) who was blinded
to the patient’s group assignment. On the basis of prior experience
and a desire to minimize artifacts, we selected an intensity detec-
tion of 17 decibels. Artifact rejection was also enhanced by using
the dual-gate TCD technique, wherein a Doppler signal had to be
detected at 2 different depths to be recognized as a true embolus.
After waveform analysis was performed, each signal was further
assessed for sound characteristics indicative of true embolization.
Patient Management
OPCAB procedures. Anesthesia was established with midazo-
lam, fentanyl, and pancuronium and maintained with isoflurane.
All patients were monitored with arterial and pulmonary artery
catheters. During cardiac displacement, blood pressure was main-
tained within a mean arterial pressure range of 60 to 70 mm Hg,
with hemodynamics adjusted by using adrenergic agents when
indicated to ensure a cardiac index of greater than 2.0 L · min1 ·
m2. Coronary grafting was performed by using one of the com-
mercially available stabilization devices (Medtronic Inc, Minne-
apolis, Minn; Genzyme Inc, Cambridge, Mass; or Guidant Inc,
Santa Clara, Calif) The patient’s temperature was maintained as
close to normal (37°C) as possible by using heated fluids and
forced-air warming.
All saphenous vein–aortic anastomoses were performed by
using the US Food and Drug Administration–approved Symmetry
Bypass System device. On completion of device deployment, the
anastomosis was inspected for leaks. If present, the leak was
closed with 7-0 Prolene sutures. Aortic clamping was not per-
formed at any time during the procedure.
S-CABG procedures. Anesthesia was established as described
previously. The perfusion apparatus consisted of the Cobe CML
membrane oxygenator (Cobe Laboratories, Lakewood, Colo), the
Sarns 7000 max pump (3M Inc, Ann Arbor, Mich), and the Pall
SP3840 arterial line filter (Pall Biomedical Products Co, Glencove,
NY). Perfusion was maintained at pump flow rates of 2.0 to 2.4 L
· min1 · m2 throughout CPB. The pump was primed with
crystalloid, and serial hematocrit levels were maintained at greater
than or equal to 0.18 with packed red blood cell supplementation
as necessary. Arterial blood gases were followed every 15 to 30
minutes to maintain arterial carbon dioxide partial pressures of 35
to 40 mm Hg and oxygen partial pressures of 150 to 250 mm Hg.
Mild hypothermia was used during CPB, with the patient cooled to
32°C to 34°C. After completion of the coronary anastomoses, the
patient was gradually rewarmed to a nasopharyngeal temperature
of 37°C in standard fashion.
In the S-CABG group all saphenous vein–aortic anastomoses
were performed by using traditional freehand techniques. Aortic
cannulation and crossclamping was performed in all patients as
part of the CPB protocol, with the crossclamp being replaced by a
partial clamp for performance of the proximal anastomoses.
Statistical Methods
Age and ejection fraction were determined for patients in the
OPCAB and S-CABG groups and compared by using indepen-
dent-samples 2-tailed t tests. Sex and the number of bypass grafts
received were also compared between the 2 groups by using Fisher
exact tests. Once the 2 groups were assessed for similarity in this
manner, a comparison of both right-sided and left-sided cerebral
microemboli counts between the groups was made by using the
Wilcoxon 2-sample rank sum test to allow for the nonnormality of
the distribution.
Results
Demographics
Fifty-three consecutive patients from June 2001 to Decem-
ber 2001 who met the study criteria underwent OPCAB
with the proximal sutureless anastomotic device for all
aorta–saphenous vein anastomoses. The demographic pro-
file of these patients is provided in Table 1. Of these
patients, 21 consented to intraoperative TCDU monitoring.
Mean age, number of grafts, and preoperative ejection frac-
tion of this subset of patients were similar to those of the
entire sample of OPCAB group as a whole. When the
demographic variables of the OPCAB group were compared
with those of the S-CABG group, no significant difference
was found in mean age, preoperative ejection fraction, or
total number of bypass grafts received (Table 2). The 2
groups did differ significantly with respect to sex distribu-
tion, with female patients comprising a relatively greater
proportion of the OPCAB group than the S-CABG group.
OPCAB Group
Fifty-three total patients underwent OPCAB with the su-
tureless anastomotic device for all proximal anastomoses
(Table 1). A total of 106 proximal anastomoses, or 2.0 
0.8 per patient, were performed. Each of these proximal
anastomoses was performed with the sutureless device. In-
traoperatively, there were no aortic complications, and no
patient required aortic clamping. Two proximal anastomo-
ses required intraoperative revision because of small leaks
at the anastomotic site after device deployment. There were
TABLE 1. Demographic profile of the OPCAB group in
which proximal aortic anastomoses were performed with
a sutureless anastomotic device
OPCAB group with
sutureless anastomotic
device
No. of patients 53
Age (y) 64.5 10.0
Race (white) 87%
Sex (male) 56.7%
Preoperative ejection fraction 49.0 12.0
Mean no. of total grafts 2.9 0.9
Mean no. of saphenous venous grafts 2.0 0.8
Intraoperative proximal anastomotic
revisions
1.8%
Length of follow-up (d) 148 57
Length of stay (d) 6.2 4.3
Postoperative take backs for bleeding 1.8%
Postoperative stroke 0%
30-day mortality 0%
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no instances, however, in which the device failed to deploy
properly. Postoperatively, there were no strokes or in-hos-
pital deaths. One (1.8%) patient required reoperation for
postoperative bleeding. On take back, a small branch of the
left internal thoracic artery was found to be the source of the
bleeding, with both of that patient’s proximal anastomoses
appearing hemostatic. Mean length of stay for the OPCAB
group was 6.2 4.3 days. After a mean follow-up of 148
57 days, there were no procedure-related rehospitalizations
or deaths in the OPCAB group. In the S-CABG group there
were no strokes, in-hospital deaths or reoperations for
bleeding. Two patients in this group required rehospitaliza-
tion, one for mediastinitis and the other for recurrent myo-
cardial infarction caused by kinking of the left internal
thoracic arterial graft.
Cerebral Microembolic Counts
A total of 21 patients in the OPCAB group and 26 patients
in the S-CABG group received continuous intraoperative
TCDU monitoring. Successful monitoring was achieved in
18 of the 21 patients in the OPCAB group in whom TCD
was attempted. Similarly, 17 of the 26 patients in the S-
CABG group were also successfully monitored. The pri-
mary reasons for unsuccessful monitoring were the inability
to obtain an adequate ultrasound signal and the inability to
maintain the signal throughout the entire period.
Embolic events were monitored and recorded separately
for the right and left cerebral circulations. Mean and median
right- and left-sided counts were calculated and compared
between groups (Figure 1). Because emboli counts were not
normally distributed, comparisons of counts between the 2
groups were made by using the Wilcoxon 2-sample rank
sum test. Patients in the OPCAB group had significantly
fewer left-sided cerebral embolic events intraoperatively
(mean, 24.9  19.2; median, 26.0) than patients in the
S-CABG group (mean, 189.9  60.4; median, 180.0; P 
.0001). A similarly significant difference in embolic counts
was also noted in the right cerebral circulation (mean of
21.9  20.7 and median of 18.0 for the OPCAB group vs
mean of 181.6 85.3 and median of 173.0 for the S-CABG
group, P  .0001).
The frequency of intraoperative embolic events during
specific time periods was also analyzed. In the OPCAB
group 100% microembolic events occurred during suture-
less anastomotic device insertion and deployment. No em-
boli were detected when the heart was displaced for perfor-
mance of the distal anastomoses. In the S-CABG group
30.0% (mean, 51.2  48.7) of the microemboli occurred
during aortic cannulation to aortic crossclamp application,
40.1% (mean, 74.4 52.1) occurred from aortic crossclamp
application to removal, 23.9% (mean 43.7 26.0) occurred
from aortic crossclamp removal to aortic decannulation, and
6.0% occurred from aortic decannulation to chest closure. A
similar temporal distribution of embolic events was found
for the right cerebral circulation of the patients in the
S-CABG group.
Discussion
We performed OPCAB in 53 patients using a sutureless
anastomotic device for all aorta–saphenous vein graft anas-
tomoses. The use of a sutureless anastomotic technique for
the proximal anastomoses was safe, with no aortic compli-
cations occurring during a total of 106 such anastomoses.
Persistent leakage from the anastomosis after device de-
ployment did occur in 2 cases, but these leakage sites were
easily repaired with only a single supplemental suture per
anastomosis. The causes of these leaks are unknown, but
they were not related to any technical difficulties with the
device or to crowding of the proximal anastomoses on the
aorta when more than one proximal sutureless graft was
performed. Postoperatively, there was one reoperation for
bleeding, with the source of bleeding identified intraopera-
tively as a small branch of the left internal thoracic artery.
There were no postoperative strokes or in-hospital deaths.
There was one late death, the cause of which was unrelated
to the patient’s OPCAB procedure.
A subset of patients in the OPCAB group underwent
intraoperative TCDU to quantitate the number of microem-
boli traversing the cerebral circulation. We compared the
results from this subset of patients with those obtained from
a group of patients undergoing standard CABG in whom
both CPB and hand-sewn proximal anastomotic techniques
were used. The patients in the S-CABG group were similar
to those in the OPCAB subset in terms of age, preoperative
ejection fraction, and the number of grafts received, al-
though the S-CABG group had a significantly larger pro-
portion of male patients. We found that the number of
microemboli generated during CABG was more than 7-fold
greater in the S-CABG group than in the OPCAB group. To
our knowledge, this is the first such demonstration that the
combined use of off-pump surgery and sutureless proximal
anastomotic devices is associated with a significant reduc-
TABLE 2. Comparison of demographic variables between
patients in the OPCAB and S-CABG groups who underwent
intraoperative TCDV
OPCAB group S-CABG group
Alpha
value
No. of patients 21 26
Age (y) 62.9 12.2 60.1 9.3 .3813*
Sex (male) 55.6% 88.5% .0305†
Preoperative ejection
fraction
55.8 10.1 52.5 10.0 .2824*
Mean no. of total grafts 3.1 0.7 3.3 .5066*
*P value standard t test.
†P value with Fisher exact test.
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tion in cerebral microemboli generation when compared
with that seen in standard CABG techniques.
The association between cerebral microemboli during
CABG and the development of postoperative neurocogni-
tive dysfunction is strong. Stump and colleagues8 performed
a prospective study of 167 patients receiving neuropsycho-
logic testing within 5 to 7 days after standard CABG.
Continuous intraoperative TCDU was also performed in
these patients. The authors found that the number of micro-
emboli detected intraoperatively correlated highly with the
development of postoperative neuropsychologic dysfunc-
tion. Specifically, 79% of patients with greater than 100
intraoperative embolic events had a neurocognitive deficit
compared with 63% of patients who had fewer than 100
embolic events. Moreover, patients who did demonstrate
postoperative neuropsychologic decline averaged twice as
many embolic events during CABG as patients who did not
have postoperative impairment. Pugsley and associates11
also examined neurocognitive outcome in 94 consecutive
patients undergoing CABG but at 8 weeks postoperatively.
In this study 43% of patients with intraoperative embolic
counts of greater than 1000 experienced postoperative cog-
nitive decline at 8 weeks compared with only 9% of patients
with fewer than 200 events.
CPB is a significant source of cerebral microemboli
during CABG. The aortic manipulation required for aortic
cannulation and clamping appears to be one of the primary
risk factors for cerebral embolism. In our study we found
that the period during cannulation to crossclamp application
resulted in approximately 30% of all microembolic events
in the S-CABG group, whereas the period involving cross-
clamp application and removal accounted for 40% of such
events. In a study of 196 patients undergoing CABG with
CPB, Stump and colleagues14 used intraoperative TCDU to
determine when cerebral microemboli occurred during the
procedure. They found that periods of aortic cannulation
and ascending aortic clamping during CPB accounted for
more than 40% of intraoperative cerebral microembolic
events. Cardiotomy suctioning is another source of cerebral
microemboli during CPB, producing acellular lipoid depos-
its that have been shown to lead to small capillary arterial
dilatations within the afferent cerebral microvasculature.
Such dilatations are believed to represent foci of central
nervous system injury that ultimately result in neurocogni-
tive dysfunction postoperatively.15,16 By eliminating the use
of CPB during coronary bypass surgery, it is thought that
many of these atheromatous and lipoid embolic events can
be avoided. Several groups of investigators have therefore
sought to determine the effect of off-pump coronary sur-
gery, in which CPB is not used, on intraoperative emboli
counts. Watters and colleagues18 performed a study of 20
patients undergoing multivessel CABG. Ten of these pa-
tients received standard CABG with CPB, whereas the other
10 patients received OPCAB. All patients were monitored
with TCDU from the time of pericardiotomy until 10 min-
utes after the last aortic instrumentation. The mean micro-
emboli count in the patients in which CPB was used was 79
compared with only 3 in patients undergoing off-pump
surgery. None of the patients in this small study had gross
neurologic dysfunction postoperatively. A similar retro-
spective review of 40 patients by Bowles and coworkers17
demonstrated that the elimination of CPB from the coronary
bypass grafting procedure significantly reduced the mean
intraoperative cerebral emboli count from 1766 to 27.
Although the use of OPCAB does appear to significantly
reduce the frequency of cerebral microemboli, it is not clear
whether this reduction in emboli counts translates into im-
proved postoperative neurocognitive function. Diegeler and
associates21 performed intraoperative TCDU and postoper-
ative neurocognitive testing in a total of 40 patients under-
going CABG. Twenty of these patients underwent OPCAB,
and the other 20 underwent CPB. The off-pump group had
significantly fewer intraoperative cerebral microemboli and
significantly less cognitive impairment in the early postop-
erative period. In another study of 60 patients undergoing
CABG, however, Lloyd and colleagues22 found no signifi-
cant difference in neurocognitive function at 12 weeks
postoperatively between patients who underwent OPCAB
Figure 1. Comparison of mean cerebral embolic counts between the OPCAB and S-CABG groups. *P < .0001 (vs
S-CABG group) by using the Wilcoxon 2-sample rank sum test.
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and those who received conventional CABG with CPB.
Moreover, a recent prospective trial of 281 patients random-
ized to either OPCAB or conventional CABG also failed to
show any statistically significant difference in the incidence
of neurocognitive deterioration at 12 months postoperatively.23
Thus it appears that simply eliminating the use of CPB
by performing CABG off pump might not prevent postop-
erative neurocognitive deterioration. This lack of outcome
benefit might be due to the fact that aortic clamping and the
embolic sequelae of such clamping are still required during
off-pump surgery to perform proximal aortic anastomoses.
In our S-CABG group, such instrumentation accounted for
up to 40% of microemboli detected. However, the advent of
sutureless anastomotic devices now makes it possible to
perform proximal aorta–saphenous vein graft anastomoses
without aortic clamping of any type. By combining off-
pump surgery with sutureless proximal aortic anastomotic
techniques, thus minimizing the degree of intraoperative
aortic manipulation, it might be possible to further reduce
the number of cerebral embolic events to such a level that
the incidence of postoperative neurocognitive deterioration
is also minimized. In the current study we have shown that
such a strategy does in fact result in fewer embolic events
than conventional CABG techniques. Although sutureless
anastomotic device deployment did cause embolic genera-
tion in the OPCAB group, the mean number of emboli
generated was considerably lower than the number of em-
boli that occurred in the S-CABG group during aortic can-
nulation, crossclamp application, and crossclamp removal.
Conversely, because aortic crossclamping is required during
CPB and accounts for the majority of emboli generated
during this procedure, there appears to be no benefit to using
a sutureless proximal anastomotic device during standard
CABG.
A major limitation of our study was our inability to
assess the individual contributions of off-pump bypass
grafting and sutureless proximal anastomoses to the reduc-
tion in cerebral embolic events. Specifically, we did not
include a group of patients in whom OPCAB was performed
with aortic crossclamping and hand-sewn proximal anasto-
moses. Such a comparison would enable us to further de-
lineate the benefits of sutureless proximal anastomoses with
regard to microemboli generation during OPCAB. A larger
study population would be required to demonstrate a dif-
ference in cerebral microembolic events between OPCAB
performed with aortic crossclamping and hand-sewn anas-
tomoses versus no crossclamping and sutureless anastomo-
ses. Unfortunately, we were not able to include a study
population of this size. However, the findings of the current
study are still relevant because they show, for the first time,
that minimizing aortic intraoperative manipulation during
CABG is associated with fewer cerebral emboli than stan-
dard CABG techniques. A second limitation of our study
was that we did not assess postoperative neurocognitive
outcomes. Although no patient from either group had post-
operative stroke, prospective long-term follow-up with
more sensitive and specific testing is required to determine
neuropsychologic outcome. However, given the strong as-
sociation between intraoperative cerebral microembolic
events during CABG and the development of postoperative
neurocognitive dysfunction, we believe that the ability to
greatly reduce the occurrence of such embolic events by
minimizing aortic manipulation will translate into improved
neurocognitive outcome when examined prospectively in
the future.
In summary, we have demonstrated, for the first time,
that efforts to minimize aortic manipulation during CABG
by eliminating CPB and by using a sutureless anastomotic
device for all proximal aortic anastomoses results in signif-
icantly fewer intraoperative cerebral embolic events. Fur-
ther investigation is warranted to determine the effects of
such a technique on neurocognitive outcome.
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